The Centers for Medicare and Medicaid Services (CMS) may grant new technology add-on payments for several medical devices and diagnostics in FY2021, the agency stated in a proposed rule this week. But CMS will end the payments for three devices as their additional funding time expires next year, the agency said.
New technology add-on payments have expired for remedē Systems, a nerve stimulator sponsored by Respicardia Inc.; Sentinel Cerebral Protection System,...